<?xml version="1.0" encoding="UTF-8"?>
<EXPERIMENT_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <EXPERIMENT accession="SRX17861607" alias="CORVASEQ-CLT-010612_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861607</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010612_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380300">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380300</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010612_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010612</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861608" alias="CORVASEQ-CLT-010613_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861608</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010613_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380301">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380301</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010613_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010613</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861609" alias="CORVASEQ-CLT-010614_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861609</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010614_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380302">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380302</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010614_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010614</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861610" alias="CORVASEQ-CLT-010615_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861610</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010615_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380303">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380303</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010615_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010615</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861611" alias="CORVASEQ-CLT-010617_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861611</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010617_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380304">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380304</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010617_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010617</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861612" alias="CORVASEQ-CLT-010618_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861612</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010618_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380305">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380305</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010618_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010618</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861613" alias="CORVASEQ-CLT-010619_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861613</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010619_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380306">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380306</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010619_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010619</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861614" alias="CORVASEQ-CLT-010620_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861614</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010620_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380307">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380307</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010620_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010620</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861615" alias="CORVASEQ-CLT-010621_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861615</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010621_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380308">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380308</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010621_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010621</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861616" alias="CORVASEQ-CLT-010622_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861616</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010622_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380309">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380309</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010622_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010622</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861617" alias="CORVASEQ-CLT-010623_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861617</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010623_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380310">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380310</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010623_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010623</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861618" alias="CORVASEQ-CLT-010624_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861618</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010624_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380311">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380311</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010624_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010624</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861619" alias="CORVASEQ-CLT-010625_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861619</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010625_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380312">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380312</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010625_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010625</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861620" alias="CORVASEQ-CLT-010627_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861620</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010627_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380313">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380313</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010627_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010627</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861621" alias="CORVASEQ-CLT-010628_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861621</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010628_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380314">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380314</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010628_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010628</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861622" alias="CORVASEQ-CLT-010629_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861622</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010629_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380315">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380315</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010629_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010629</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861623" alias="CORVASEQ-CLT-010630_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861623</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010630_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380316">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380316</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010630_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010630</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861624" alias="CORVASEQ-CLT-010631_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861624</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010631_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380317">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380317</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010631_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010631</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861625" alias="CORVASEQ-CLT-010632_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861625</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010632_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380318">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380318</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010632_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010632</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861626" alias="CORVASEQ-CLT-010634_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861626</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010634_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380319">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380319</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010634_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010634</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861627" alias="CORVASEQ-CLT-010635_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861627</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010635_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380320">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380320</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010635_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010635</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861628" alias="CORVASEQ-CLT-010636_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861628</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010636_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380321">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380321</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010636_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010636</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861629" alias="CORVASEQ-CLT-010637_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861629</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010637_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380322">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380322</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010637_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010637</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861630" alias="CORVASEQ-CLT-010667_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861630</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010667_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380323">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380323</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010667_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010667</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861631" alias="CORVASEQ-CLT-010669_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861631</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010669_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380324">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380324</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010669_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010669</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861632" alias="CORVASEQ-CLT-010670_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861632</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010670_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380325">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380325</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010670_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010670</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861633" alias="CORVASEQ-CLT-010671_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861633</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010671_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380326">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380326</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010671_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010671</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861634" alias="CORVASEQ-CLT-010672_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861634</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010672_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380327">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380327</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010672_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010672</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861635" alias="CORVASEQ-CLT-010673_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861635</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010673_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380328">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380328</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010673_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010673</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861636" alias="CORVASEQ-CLT-010674_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861636</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010674_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380329">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380329</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010674_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010674</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861637" alias="CORVASEQ-CLT-010675_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861637</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010675_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380330">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380330</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010675_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010675</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861638" alias="CORVASEQ-CLT-010676_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861638</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010676_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380331">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380331</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010676_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010676</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861639" alias="CORVASEQ-CLT-010677_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861639</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010677_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380333">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380333</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010677_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010677</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861640" alias="CORVASEQ-CLT-010678_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861640</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010678_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380332">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380332</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010678_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010678</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861641" alias="CORVASEQ-CLT-010639_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861641</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010639_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380334">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380334</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010639_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010639</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861642" alias="CORVASEQ-CLT-010640_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861642</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010640_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380335">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380335</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010640_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010640</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861643" alias="CORVASEQ-CLT-010642_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861643</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010642_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380336">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380336</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010642_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010642</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861644" alias="CORVASEQ-CLT-010643_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861644</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010643_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380337">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380337</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010643_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010643</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861645" alias="CORVASEQ-CLT-010644_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861645</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010644_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380338">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380338</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010644_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010644</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861646" alias="CORVASEQ-CLT-010645_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861646</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010645_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380339">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380339</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010645_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010645</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861647" alias="CORVASEQ-CLT-010647_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861647</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010647_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380340">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380340</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010647_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010647</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861648" alias="CORVASEQ-CLT-010648_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861648</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010648_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380341">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380341</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010648_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010648</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861649" alias="CORVASEQ-CLT-010649_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861649</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010649_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380342">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380342</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010649_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010649</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861650" alias="CORVASEQ-CLT-010650_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861650</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010650_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380343">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380343</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010650_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010650</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861651" alias="CORVASEQ-CLT-010651_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861651</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010651_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380344">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380344</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010651_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010651</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861652" alias="CORVASEQ-CLT-010652_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861652</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010652_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380345">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380345</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010652_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010652</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861653" alias="CORVASEQ-CLT-010653_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861653</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010653_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380346">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380346</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010653_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010653</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861654" alias="CORVASEQ-CLT-010654_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861654</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010654_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380347">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380347</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010654_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010654</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861655" alias="CORVASEQ-CLT-010655_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861655</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010655_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380348">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380348</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010655_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010655</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861656" alias="CORVASEQ-CLT-010656_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861656</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010656_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380349">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380349</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010656_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010656</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861657" alias="CORVASEQ-CLT-010658_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861657</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010658_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380350">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380350</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010658_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010658</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861658" alias="CORVASEQ-CLT-010660_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861658</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010660_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380351">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380351</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010660_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010660</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861659" alias="CORVASEQ-CLT-010662_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861659</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010662_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380352">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380352</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010662_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010662</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX17861660" alias="CORVASEQ-CLT-010664_SRA">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX17861660</PRIMARY_ID>
      <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010664_SRA</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical, USA:North Carolina</TITLE>
    <STUDY_REF accession="SRP378240">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP378240</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA720702</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Viral sequencing was performed following a tiling amplicon strategy using the vss2b primer scheme. Sequencing was performed using a PromethIon by Oxford Nanopore Technologies . Libraries were prepared using NEBNext® ARTIC SARS-CoV-2 Companion Kit</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15380353">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15380353</PRIMARY_ID>
          <EXTERNAL_ID namespace="CLT">CORVASEQ-CLT-010664_BioSample</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CORVASEQ-CLT-010664</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>PromethION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
</EXPERIMENT_SET>
